Abstract
Søren NF. Hostrup, Suganthiya S. Croosu, Johan Røikjer, Carsten D. Mørch, Asbjørn M. Drewes, Birgitte Brock, Janusiya A. Muthulingam, Tine M. Hansen, Jens B. Frøkjær
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045
10.1016/j.diabres.2021.109119 · 2022
Accelerated brain aging in individuals with diabetes: association with poor glycemic control and increased all-cause mortality
10.1016/j.psyneuen.2022.105921 · 2022
Diabetes, prediabetes, and brain aging: the role of healthy lifestyle
10.2337/dc24-0860 · 2024
Patterns of regional brain atrophy and brain aging in middle- and older-aged adults with type 1 diabetes
10.1001/jamanetworkopen.2023.16182 · 2023
Advanced BrainAGE in older adults with type 2 diabetes mellitus
10.3389/fnagi.2013.00090 · 2013
Diabetic neuropathy
2019
Magnetic resonance neuroimaging study of brain structural differences in diabetic peripheral neuropathy
10.2337/dc13-2610 · 2014
Gray matter brain alterations in type 1 diabetes - findings based on detailed phenotyping of neuropathy status
10.1055/a-1835-1877 · 2022
Macrostructural brain changes in patients with longstanding type 1 diabetes mellitus - a cortical thickness analysis study
10.1055/s-0033-1345120 · 2013
Structural and functional abnormalities of the primary somatosensory cortex in diabetic peripheral neuropathy: a multimodal MRI study
10.2337/db18-0509 · 2019
Prevalence and impact on quality of life of peripheral neuropathy with or without neuropathic pain in type 1 and type 2 diabetic patients attending hospital outpatients clinics
10.1016/j.diabet.2008.11.004 · 2009
Prevalence and determinants of painful and painless neuropathy in type 1 diabetes mellitus
10.3389/fendo.2019.00402 · 2019
Prevalence of painful and painless diabetic peripheral neuropathy in the Northern Danish Region: a population-based study
10.1016/j.pcd.2024.08.006 · 2024
Brain-predicted age difference estimated using DeepBrainNet is significantly associated with pain and function-a multi-institutional and multiscanner study
10.1097/j.pain.0000000000002984 · 2023
Chronic pain is associated with a brain aging biomarker in community-dwelling older adults
10.1097/j.pain.0000000000001491 · 2019
Painful diabetic neuropathy is associated with accelerated epigenetic aging
10.1007/s11357-025-01516-w · 2025
Reduced gray matter brain volume and cortical thickness in adults with type 1 diabetes and neuropathy
10.1016/j.neures.2021.10.002 · 2022
Cognitive performance in type 1 diabetes patients is associated with cerebral white matter volume
10.1007/s00125-007-0714-0 · 2007
Altered surface-based brain morphometry in type 1 diabetes and neuropathic pain
10.1016/j.neuroscience.2024.12.033 · 2025
Alterations of peripheral cytokines, BDNF, and surface-based morphometry indices in T2DM patients without cognitive impairment
10.3389/fnins.2023.1141261 · 2023
Alterations in functional connectivity of thalamus and primary somatosensory cortex in painful and painless diabetic peripheral neuropathy
10.2337/dc22-0587 · 2023
Altered functional connectivity between brain structures in adults with type 1 diabetes and polyneuropathy
10.1016/j.brainres.2022.147882 · 2022
Brain spectroscopy reveals that N-acetylaspartate is associated to peripheral sensorimotor neuropathy in type 1 diabetes
10.1016/j.jdiacomp.2018.12.016 · 2019
Neuropathic phenotypes of type 1 diabetes are related to different signatures of magnetic resonance spectroscopy-assessed brain metabolites
10.1016/j.clinph.2024.06.017 · 2024
Central nervous system microstructural alterations in type 1 diabetes mellitus: a systematic review of diffusion Tensor imaging studies
10.1016/j.diabres.2023.110645 · 2023
Cerebrospinal fluid levels of Alzheimer’s disease biomarkers in middle-aged patients with type 1 diabetes
10.1007/s00125-014-3333-6 · 2014
Quantification of white matter hyperintensities in type 1 diabetes and its relation to neuropathy and clinical characteristics
10.1016/j.brainres.2024.149288 · 2025
Structural brain alterations in key somatosensory and nociceptive regions in diabetic peripheral neuropathy
10.2337/dc22-1123 · 2023
Multimodal MRI analysis selecting key brain features for machine learning based classification of diabetic neuropathic pain and phenotypes
10.1016/j.jns.2025.123701 · 2025
Unresolved referenced work
Kept as external metadata until matched
Brain structure ages-a new biomarker for multi-disease classification
10.1002/hbm.26558 · 2024
Role of sural sensory nerve in the assessment of type 2 diabetes mellitus peripheral polyneuropathy in adults
10.25258/ijddt.12.3.33 · 2022
Brain aging mechanisms with mechanical manifestations
10.1016/j.mad.2021.111575 · 2021
A new look at painful diabetic neuropathy
10.1016/j.diabres.2018.08.020 · 2018
From metabolic dysregulation to neurodegenerative pathology: the role of hyperglycemia, oxidative stress, and blood-brain barrier breakdown in T2D-driven Alzheimer’s disease
10.1007/s11011-025-01700-z · 2025
Brain age as a surrogate marker for cognitive performance in multiple sclerosis
10.1111/ene.15473 · 2022
Brain age gap, dementia risk factors and cognition in middle age
10.1093/braincomms/fcae392 · 2024
A nonlinear simulation framework supports adjusting for age when analyzing BrainAGE
10.3389/fnagi.2018.00317 · 2018
Point-of-care nerve conduction device predicts the severity of diabetic polyneuropathy: a quantitative, but easy-to-use, prediction model
10.1111/jdi.13386 · 2021
Validity and reliability of a point-of-care nerve conduction device in diabetes patients
10.1111/jdi.13007 · 2019
No additional external references are available.